Arca Biopharma | ABIO - Current Assets


Arca Biopharma reported $355.16M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Amgen USD 29.06B 1.17B Dec/2025
Arca Biopharma USD 355.16M 23.15M Sep/2025
Biogen USD 8.97B 37.5M Dec/2025
Brainstorm Cell Therapeutics USD 508K 1.01M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Capricor Therapeutics USD 100.95M 23.18M Sep/2025
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
CSL USD 11.85B 1000K Dec/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Daiichi Sankyo JPY 2.1T 218.5B Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Grifols EUR 6.28B 92.48M Sep/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Otsuka Holdings JPY 1.62T 113.12B Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
United Therapeutics USD 3.7B 208.5M Dec/2025